Author

A. Sittner

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:host-pathogen & immune response· 3 Organism:rat· 2 Organism:bacteria (other)· 1 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1 Organism:zebrafish· 1

Frequent Co-Authors

H. Levy· 4 shared I. Glinert· 4 shared S. Weiss· 4 shared E. Bar-David· 3 shared A. Ben-Shmuel· 2 shared A. Beth-Din· 2 shared B. Politi· 2 shared H. Achdout· 2 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersMicrobiology

H. Levy

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Doxycycline Levofloxacin or Moxifloxacin are superior to ciprofloxacin in treating anthrax meningitis in rabbits

A. Ben-Smuel, I. Glinert, A. Sittner, E. Bar-David, J. Schlomovitz, H. Levy, S. Weiss

This study compares the efficacy of Doxycycline, Levofloxacin, and Moxifloxacin to Ciprofloxacin in treating anthrax meningitis in rabbits, finding the former more effective.

bioRxiv · Dec 6, 2023 · PreprintMicrobiology

Alternate response of Bacillus anthracis atxA and acpA to serum, HCO3- and CO2

I. Glinert, E. Bar-David, A. Ben-Smueal, A. Sittner, R. Puni, S. Laredo, D. Kobiler, S. Weiss, H. Levy

This study investigates how Bacillus anthracis regulates toxin and capsule production in response to serum, HCO3-, and CO2 using a modified medium system.

bioRxiv · Feb 21, 2022 · PreprintMicrobiology

Nonclinical Safety and Immunogenicity of an rVSV-ΔG-SARS-CoV-2-S vaccine in mice, hamsters, rabbits and pigs

N. Madar-Balakirski, A. Rosner, S. Melamed, B. Politi, M. Steiner, H. Tamir, Y. Yahalom Ronen, E. Bar-David, A. Ben-Shmuel, A. Sittner, I. Glinert, S. Weiss, E. Bar-Haim, H. Cohen, U. Elia, , H. Marcus

This study evaluates the safety, immunogenicity, and efficacy of an rVSV-ΔG-SARS-CoV-2-S vaccine in multiple animal species, finding no adverse effects and a robust immune response.

bioRxiv · Jul 6, 2021Pharmacology & Toxicology

A single dose of recombinant VSV-{triangleup}G-spike vaccine provides protection against SARS-CoV-2 challenge

Y. Yahalom-Ronen, H. Tamir, S. Melamed, B. Politi, O. Shifman, H. Achdout, E. B. Vitner, O. Israeli, E. Milrot, D. Stein, I. Cohen-Gihon, S. Lazar, H. Gutman, I. Glinert, L. Cherry, , T. Israely

This study develops a recombinant VSV-ΔG-spike vaccine that provides single-dose protection against SARS-CoV-2 in hamsters by inducing neutralizing antibodies and preventing lung pathology.

bioRxiv · Jun 18, 2020Microbiology